WMAR: FDA Raises Concerns After Inspecting Emergent BioSolutions

SMS
WMAR: FDA Raises Concerns After Inspecting Emergent BioSolutions
The FDA spent eight days inspecting Baltimore's Emergent BioSolutions plant which was set to make the Johnson & Johnson vaccine.
SHOW TRANSCRIPT